尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Reider Paul. Officer active across 1 company, notably Coherus BioSciences, Inc.. Aggregated, 7 reports have been published. Activity tracked since 1 April 2023. The latest transaction was filed on 20 January 2025 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Reider Paul is Chief Commercial Officer at Coherus BioSciences, Inc. The record shows 7 filings, and the sampled recent filings run from 2023-04-04 to 2025-01-22. In this recent sample, the transactions are all listed as Retenue fiscale, with sum_buy_eur at 0 and sum_sell_eur at 0.